MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu

MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu

Human adult stem cells, including umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs), have recently been considered a promising alternative treatment for inflammatory bowel disease (IBD) due to their unique immunomodulatory properties and ability to promote tissue regeneration. However,...

Full description

Bibliographic Details
Main Authors: Byung-Chul Lee, Nari Shin, Jin Young Lee, Insung Kang, Jae-Jun Kim, Seung Eun Lee, Soon Won Choi, Gill A. Webster, Kyung-Sun Kang
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Immunology
Subjects:
stem cell therapy
NOD2 and TLR9 signaling
immune modulator
inflammatory bowel diseases
migration capacity
immunosuppression
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01078/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2018.01078/full

Similar Items